The Valley Desk

Clinical trial reportThe Lancet. Respiratory medicinePublished

Long-term safety and efficacy of twice-yearly depemokimab in type 2 asthma with an eosinophilic phenotype: 2-year integrated analysis of the phase 3a SWIFT-1 and SWIFT-2 studies and AGILE open-label extension

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names GSK. Affiliation source

Institution
GSK

Publication record

Type
Clinical trial report
Venue
The Lancet. Respiratory medicine
Published
PubMed ID
42956801
Added to directory
Source checked

Report a correction or request removal